| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,685 |
11,782 |
$860K |
| 99199 |
Unlisted special service, procedure or report |
59,970 |
45,451 |
$322K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,287 |
3,948 |
$244K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,608 |
1,094 |
$104K |
| 99215 |
Prolong outpt/office vis |
724 |
608 |
$58K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
893 |
575 |
$54K |
| 99205 |
Prolong outpt/office vis |
393 |
300 |
$47K |
| 94060 |
|
1,793 |
1,373 |
$45K |
| 94726 |
|
2,011 |
1,421 |
$36K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,707 |
4,104 |
$31K |
| 82947 |
|
13,870 |
9,833 |
$30K |
| 93000 |
|
2,901 |
2,039 |
$24K |
| 99401 |
|
2,806 |
2,030 |
$16K |
| 99406 |
|
2,277 |
1,771 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
9,085 |
6,458 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
548 |
348 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,491 |
946 |
$11K |
| 90688 |
|
1,345 |
817 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
107 |
81 |
$9K |
| 99443 |
|
204 |
130 |
$9K |
| 82570 |
|
2,611 |
1,775 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
902 |
665 |
$7K |
| 81003 |
|
4,902 |
3,318 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
147 |
104 |
$4K |
| 90756 |
|
627 |
329 |
$4K |
| 99442 |
|
100 |
79 |
$3K |
| 99454 |
|
427 |
385 |
$3K |
| 90656 |
|
169 |
130 |
$1K |
| 81025 |
|
264 |
188 |
$1K |
| 82044 |
|
612 |
434 |
$915.38 |
| 99457 |
|
132 |
130 |
$878.09 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
393 |
205 |
$653.26 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
1,676 |
1,201 |
$600.66 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
108 |
89 |
$599.19 |
| 87905 |
|
59 |
40 |
$552.52 |
| 3044F |
|
2,472 |
1,750 |
$497.81 |
| 87808 |
|
60 |
41 |
$475.52 |
| G0008 |
Administration of influenza virus vaccine |
920 |
713 |
$172.61 |
| 99458 |
|
14 |
14 |
$113.40 |
| 94760 |
|
2,861 |
2,267 |
$98.71 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
46 |
39 |
$31.68 |
| 3045F |
|
106 |
94 |
$21.07 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
69 |
43 |
$20.41 |
| 83037 |
|
216 |
191 |
$20.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
50 |
38 |
$0.12 |
| 3077F |
|
304 |
228 |
$0.00 |
| 99091 |
|
49 |
37 |
$0.00 |
| 3078F |
|
1,002 |
819 |
$0.00 |
| 3074F |
|
1,194 |
977 |
$0.00 |
| 3079F |
|
745 |
602 |
$0.00 |
| 3075F |
|
453 |
363 |
$0.00 |
| 3080F |
|
170 |
133 |
$0.00 |
| 90674 |
|
349 |
328 |
$0.00 |